A detailed history of Capital Group Private Client Services, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Group Private Client Services, Inc. holds 1,469,574 shares of ABT stock, worth $153 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares
1,469,574
Previous 1,157,260 26.99%
Holding current value
$153 Million
Previous $127 Million 31.13%
% of portfolio
1.77%
Previous 1.36%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $34.2 Million - $37.8 Million
312,314 Added 26.99%
1,469,574 $167 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $172,894 - $211,636
1,917 Added 0.17%
1,157,260 $127 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $2.9 Million - $3.47 Million
30,305 Added 2.69%
1,155,343 $112 Million
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $3.48 Million - $3.88 Million
34,538 Added 3.17%
1,125,038 $123 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $3.35 Million - $3.94 Million
34,545 Added 3.27%
1,090,500 $110 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $2.01 Million - $2.36 Million
21,188 Added 2.05%
1,055,955 $116 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $2.62 Million - $3.03 Million
27,067 Added 2.69%
1,034,767 $100 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $702,241 - $848,785
-6,880 Reduced 0.68%
1,007,700 $109 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $1.2 Million - $1.46 Million
10,534 Added 1.05%
1,014,580 $120 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $1.39 Million - $1.7 Million
-12,013 Reduced 1.18%
1,004,046 $141 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $119 Million - $131 Million
1,016,059 New
1,016,059 $120 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Capital Group Private Client Services, Inc. Portfolio

Follow Capital Group Private Client Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.